Analyst Activity – BMO Capital Markets Raises Its Price Target On MEDNAX (NYSE:MD) to $58.00

Analyst Ratings For MEDNAX (NYSE:MD)

Story continues below

Today, BMO Capital Markets raised its price target on MEDNAX (NYSE:MD) to $58.00 per share.

Some recent analyst ratings include

  • 2/9/2018-Mizuho Reiterated Rating of Neutral .
  • 1/24/2018-Stifel Nicolaus Reiterated Rating of Hold.

Recent Insider Trading Activity For MEDNAX (NYSE:MD)
MEDNAX (NYSE:MD) has insider ownership of 2.40% and institutional ownership of 95.22%.

  • On 12/12/2017 John C Pepia, Insider, sold 3,000 with an average share price of $51.58 per share and the total transaction amounting to $154,740.00.
  • On 11/3/2017 Cesar L Alvarez, Director, sold 10,668 with an average share price of $42.59 per share and the total transaction amounting to $454,350.12.
  • On 9/12/2017 John C Pepia, Insider, sold 3,000 with an average share price of $42.85 per share and the total transaction amounting to $128,550.00.
  • On 6/14/2017 Md Pascal J Goldschmidt, Director, sold 1,969 with an average share price of $57.57 per share and the total transaction amounting to $113,355.33.
  • On 6/1/2017 Joseph M Calabro, Insider, sold 23,327 with an average share price of $55.00 per share and the total transaction amounting to $1,282,985.00.
  • On 5/5/2017 Manuel Kadre, Director, bought 21,704 with an average share price of $55.79 per share and the total transaction amounting to $1,210,866.16.
  • On 5/5/2017 Vivian Lopez-Blanco, CFO, sold 7,778 with an average share price of $55.82 per share and the total transaction amounting to $434,167.96.

Recent Trading Activity for MEDNAX (NYSE:MD)
Shares of MEDNAX closed the previous trading session at 54.75 up +0.81 1.50% with 53.130001068115234 shares trading hands.

An ad to help with our costs